APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Saxagliptin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Saxagliptin Industry Growth and Trends Forecast to 2032

Report ID 174034080126 December 202597 pages

Choose your research edition.

Industry ResearchSaxagliptin Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Saxagliptin Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Saxagliptin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Saxagliptin Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Saxagliptin Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Saxagliptin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Saxagliptin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Saxagliptin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Saxagliptin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Saxagliptin include Bristol-Myers Squibb Company, Minxiang Pharma, Taizhou Canova Bio-technology, Tapi Teva, AstraZeneca, Hebei Kangtai Pharma, Huaman Xincaiiao Keji and Tianjin Scipharmacn, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Saxagliptin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Saxagliptin market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Saxagliptin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Saxagliptin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Saxagliptin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Saxagliptin Market by Company

Bristol-Myers Squibb Company

Minxiang Pharma

Taizhou Canova Bio-technology

Tapi Teva

AstraZeneca

Hebei Kangtai Pharma

Huaman Xincaiiao Keji

Tianjin Scipharmacn

Saxagliptin Segment by Type

2.5mg

5mg

Saxagliptin Segment by Application

Hospital

Clinic

Others

Saxagliptin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Saxagliptin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Saxagliptin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Saxagliptin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Saxagliptin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Saxagliptin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 2.5mg Table 2. Major Company of 5mg Table 3. Global Saxagliptin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Saxagliptin Sales by Type (2021-2026) & (K Units) Table 5. Global Saxagliptin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Saxagliptin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Saxagliptin Sales Market Share in Value by Type (2021-2026) Table 8. Global Saxagliptin Price by Type (2021-2026) & (US$/Unit) Table 9. Global Saxagliptin Sales by Type (2027-2032) & (K Units) Table 10. Global Saxagliptin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Saxagliptin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Saxagliptin Sales Market Share in Value by Type (2027-2032) Table 13. Global Saxagliptin Price by Type (2027-2032) & (US$/Unit) Table 14. North America Saxagliptin Sales by Type (2021-2026) & (K Units) Table 15. North America Saxagliptin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Saxagliptin Sales by Type (2021-2026) & (K Units) Table 17. Europe Saxagliptin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Saxagliptin Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Saxagliptin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Saxagliptin Sales by Type (2021-2026) & (K Units) Table 21. Latin America Saxagliptin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Saxagliptin Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Saxagliptin Sales by Type (2021-2026) & (US$ Million) Table 24. Saxagliptin Industry Trends Table 25. Saxagliptin Industry Drivers Table 26. Saxagliptin Industry Opportunities and Challenges Table 27. Saxagliptin Industry Restraints Table 28. Global Saxagliptin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Saxagliptin Revenue Market Share by Company (2021-2026) Table 30. Global Saxagliptin Sales by Company (2021-2026) & (K Units) Table 31. Global Saxagliptin Sales Share by Company (2021-2026) Table 32. Global Saxagliptin Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Saxagliptin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Saxagliptin Major Company Production Sites and Headquarters Table 35. Global Saxagliptin Company, Product Type & Application Table 36. Global Saxagliptin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Saxagliptin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Saxagliptin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Saxagliptin Sales by Region (2021-2026) & (K Units) Table 41. Global Saxagliptin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Saxagliptin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Saxagliptin Sales Market Share in Value by Region (2021-2026) Table 44. Global Saxagliptin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Saxagliptin Sales by Region (2027-2032) & (K Units) Table 46. Global Saxagliptin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Saxagliptin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Saxagliptin Sales Market Share in Value by Region (2027-2032) Table 49. Global Saxagliptin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Saxagliptin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Saxagliptin Sales by Application (2021-2026) & (K Units) Table 52. Global Saxagliptin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Saxagliptin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Saxagliptin Sales Market Share in Value by Application (2021-2026) Table 55. Global Saxagliptin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Saxagliptin Sales by Application (2027-2032) & (K Units) Table 57. Global Saxagliptin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Saxagliptin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Saxagliptin Sales Market Share in Value by Application (2027-2032) Table 60. Global Saxagliptin Price by Application (2027-2032) & (US$/Unit) Table 61. North America Saxagliptin Sales by Application (2021-2026) & (K Units) Table 62. North America Saxagliptin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Saxagliptin Sales by Application (2021-2026) & (K Units) Table 64. Europe Saxagliptin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Saxagliptin Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Saxagliptin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Saxagliptin Sales by Application (2021-2026) & (K Units) Table 68. Latin America Saxagliptin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Saxagliptin Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Saxagliptin Sales by Application (2021-2026) & (US$ Million) Table 71. Bristol-Myers Squibb Company Company Information Table 72. Bristol-Myers Squibb Company Business Overview Table 73. Bristol-Myers Squibb Company Saxagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bristol-Myers Squibb Company Saxagliptin Product Portfolio Table 75. Bristol-Myers Squibb Company Recent Development Table 76. Minxiang Pharma Company Information Table 77. Minxiang Pharma Business Overview Table 78. Minxiang Pharma Saxagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Minxiang Pharma Saxagliptin Product Portfolio Table 80. Minxiang Pharma Recent Development Table 81. Taizhou Canova Bio-technology Company Information Table 82. Taizhou Canova Bio-technology Business Overview Table 83. Taizhou Canova Bio-technology Saxagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Taizhou Canova Bio-technology Saxagliptin Product Portfolio Table 85. Taizhou Canova Bio-technology Recent Development Table 86. Tapi Teva Company Information Table 87. Tapi Teva Business Overview Table 88. Tapi Teva Saxagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Tapi Teva Saxagliptin Product Portfolio Table 90. Tapi Teva Recent Development Table 91. AstraZeneca Company Information Table 92. AstraZeneca Business Overview Table 93. AstraZeneca Saxagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. AstraZeneca Saxagliptin Product Portfolio Table 95. AstraZeneca Recent Development Table 96. Hebei Kangtai Pharma Company Information Table 97. Hebei Kangtai Pharma Business Overview Table 98. Hebei Kangtai Pharma Saxagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Hebei Kangtai Pharma Saxagliptin Product Portfolio Table 100. Hebei Kangtai Pharma Recent Development Table 101. Huaman Xincaiiao Keji Company Information Table 102. Huaman Xincaiiao Keji Business Overview Table 103. Huaman Xincaiiao Keji Saxagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Huaman Xincaiiao Keji Saxagliptin Product Portfolio Table 105. Huaman Xincaiiao Keji Recent Development Table 106. Tianjin Scipharmacn Company Information Table 107. Tianjin Scipharmacn Business Overview Table 108. Tianjin Scipharmacn Saxagliptin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Tianjin Scipharmacn Saxagliptin Product Portfolio Table 110. Tianjin Scipharmacn Recent Development Table 111. North America Saxagliptin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America Saxagliptin Sales by Country (2021-2026) & (K Units) Table 113. North America Saxagliptin Sales Market Share by Country (2021-2026) Table 114. North America Saxagliptin Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America Saxagliptin Sales Market Share Forecast by Country (2027-2032) Table 116. North America Saxagliptin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Saxagliptin Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Saxagliptin Market Share by Country (2021-2026) Table 119. North America Saxagliptin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Saxagliptin Market Share Forecast by Country (2027-2032) Table 121. Europe Saxagliptin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe Saxagliptin Sales by Country (2021-2026) & (K Units) Table 123. Europe Saxagliptin Sales Market Share by Country (2021-2026) Table 124. Europe Saxagliptin Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe Saxagliptin Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Saxagliptin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Saxagliptin Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Saxagliptin Market Share by Country (2021-2026) Table 129. Europe Saxagliptin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Saxagliptin Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Saxagliptin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Saxagliptin Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific Saxagliptin Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Saxagliptin Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific Saxagliptin Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Saxagliptin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Saxagliptin Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Saxagliptin Market Share by Country (2021-2026) Table 139. Asia-Pacific Saxagliptin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Saxagliptin Market Share Forecast by Country (2027-2032) Table 141. Latin America Saxagliptin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America Saxagliptin Sales by Country (2021-2026) & (K Units) Table 143. Latin America Saxagliptin Sales Market Share by Country (2021-2026) Table 144. Latin America Saxagliptin Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America Saxagliptin Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Saxagliptin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Saxagliptin Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Saxagliptin Market Share by Country (2021-2026) Table 149. Latin America Saxagliptin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Saxagliptin Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Saxagliptin Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Saxagliptin Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa Saxagliptin Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Saxagliptin Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Saxagliptin Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Saxagliptin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Saxagliptin Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Saxagliptin Market Share by Country (2021-2026) Table 159. Middle East and Africa Saxagliptin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Saxagliptin Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Saxagliptin Distributors List Table 164. Saxagliptin Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Saxagliptin Image Figure 2. Global Saxagliptin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Saxagliptin Market Size (2021-2032) & (US$ Million) Figure 4. Global Saxagliptin Sales (2021-2032) & (K Units) Figure 5. 2.5mg Image Figure 6. Global 2.5mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 5mg Image Figure 8. Global 5mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Saxagliptin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Saxagliptin Market Share by Type 2025 VS 2032 Figure 11. North America Saxagliptin Sales Market Share in Volume by Type in 2025 Figure 12. North America Saxagliptin Sales Market Share in Value by Type in 2025 Figure 13. Europe Saxagliptin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Saxagliptin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Saxagliptin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Saxagliptin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Saxagliptin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Saxagliptin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Saxagliptin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Saxagliptin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Saxagliptin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Saxagliptin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Saxagliptin Market Share by Application 2025 VS 2032 Figure 31. North America Saxagliptin Sales Market Share in Volume by Application in 2025 Figure 32. North America Saxagliptin Sales Market Share in Value by Application in 2025 Figure 33. Europe Saxagliptin Sales Market Share in Volume by Application in 2025 Figure 34. Europe Saxagliptin Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Saxagliptin Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Saxagliptin Sales Market Share in Value by Application in 2025 Figure 37. Latin America Saxagliptin Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Saxagliptin Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Saxagliptin Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Saxagliptin Sales Market Share in Value by Application in 2025 Figure 41. North America Saxagliptin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Saxagliptin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Saxagliptin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Saxagliptin Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Saxagliptin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Saxagliptin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Saxagliptin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Saxagliptin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Saxagliptin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Saxagliptin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Saxagliptin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Saxagliptin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Saxagliptin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Saxagliptin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Saxagliptin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Saxagliptin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Saxagliptin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Saxagliptin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Saxagliptin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Saxagliptin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Saxagliptin Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Saxagliptin Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5mg
  • 5mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Bristol-Myers Squibb Company
  • Minxiang Pharma
  • Taizhou Canova Bio-technology
  • Tapi Teva
  • AstraZeneca
  • Hebei Kangtai Pharma
  • Huaman Xincaiiao Keji
  • Tianjin Scipharmacn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Saxagliptin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Saxagliptin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Saxagliptin Market by Type
  6. 1.3.1 2.5mg
  7. 1.3.2 5mg
  8. 1.4 Global Saxagliptin Market Size by Type
  9. 1.4.1 Global Saxagliptin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Saxagliptin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Saxagliptin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Saxagliptin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Saxagliptin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Saxagliptin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Saxagliptin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Saxagliptin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Saxagliptin Industry Trends
  2. 2.2 Saxagliptin Industry Drivers
  3. 2.3 Saxagliptin Industry Opportunities and Challenges
  4. 2.4 Saxagliptin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Saxagliptin Revenue (2021-2026)
  2. 3.2 Global Top Players by Saxagliptin Sales (2021-2026)
  3. 3.3 Global Top Players by Saxagliptin Price (2021-2026)
  4. 3.4 Global Saxagliptin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Saxagliptin Major Company Production Sites & Headquarters
  6. 3.6 Global Saxagliptin Company, Product Type & Application
  7. 3.7 Global Saxagliptin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Saxagliptin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Saxagliptin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Saxagliptin Tier 1, Tier 2, and Tier 3
4 Saxagliptin Regional Status and Outlook
  1. 4.1 Global Saxagliptin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Saxagliptin Historic Market Size by Region
  3. 4.2.1 Global Saxagliptin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Saxagliptin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Saxagliptin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Saxagliptin Forecasted Market Size by Region
  7. 4.3.1 Global Saxagliptin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Saxagliptin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Saxagliptin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Saxagliptin by Application
  1. 5.1 Saxagliptin Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Saxagliptin Market Size by Application
  6. 5.2.1 Global Saxagliptin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Saxagliptin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Saxagliptin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Saxagliptin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Saxagliptin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Saxagliptin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Saxagliptin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Saxagliptin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bristol-Myers Squibb Company
  2. 6.1.1 Bristol-Myers Squibb Company Company Information
  3. 6.1.2 Bristol-Myers Squibb Company Business Overview
  4. 6.1.3 Bristol-Myers Squibb Company Saxagliptin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bristol-Myers Squibb Company Saxagliptin Product Portfolio
  6. 6.1.5 Bristol-Myers Squibb Company Recent Developments
  7. 6.2 Minxiang Pharma
  8. 6.2.1 Minxiang Pharma Company Information
  9. 6.2.2 Minxiang Pharma Business Overview
  10. 6.2.3 Minxiang Pharma Saxagliptin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Minxiang Pharma Saxagliptin Product Portfolio
  12. 6.2.5 Minxiang Pharma Recent Developments
  13. 6.3 Taizhou Canova Bio-technology
  14. 6.3.1 Taizhou Canova Bio-technology Company Information
  15. 6.3.2 Taizhou Canova Bio-technology Business Overview
  16. 6.3.3 Taizhou Canova Bio-technology Saxagliptin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Taizhou Canova Bio-technology Saxagliptin Product Portfolio
  18. 6.3.5 Taizhou Canova Bio-technology Recent Developments
  19. 6.4 Tapi Teva
  20. 6.4.1 Tapi Teva Company Information
  21. 6.4.2 Tapi Teva Business Overview
  22. 6.4.3 Tapi Teva Saxagliptin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Tapi Teva Saxagliptin Product Portfolio
  24. 6.4.5 Tapi Teva Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Saxagliptin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Saxagliptin Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 Hebei Kangtai Pharma
  32. 6.6.1 Hebei Kangtai Pharma Company Information
  33. 6.6.2 Hebei Kangtai Pharma Business Overview
  34. 6.6.3 Hebei Kangtai Pharma Saxagliptin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hebei Kangtai Pharma Saxagliptin Product Portfolio
  36. 6.6.5 Hebei Kangtai Pharma Recent Developments
  37. 6.7 Huaman Xincaiiao Keji
  38. 6.7.1 Huaman Xincaiiao Keji Company Information
  39. 6.7.2 Huaman Xincaiiao Keji Business Overview
  40. 6.7.3 Huaman Xincaiiao Keji Saxagliptin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Huaman Xincaiiao Keji Saxagliptin Product Portfolio
  42. 6.7.5 Huaman Xincaiiao Keji Recent Developments
  43. 6.8 Tianjin Scipharmacn
  44. 6.8.1 Tianjin Scipharmacn Company Information
  45. 6.8.2 Tianjin Scipharmacn Business Overview
  46. 6.8.3 Tianjin Scipharmacn Saxagliptin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Tianjin Scipharmacn Saxagliptin Product Portfolio
  48. 6.8.5 Tianjin Scipharmacn Recent Developments
7 North America by Country
  1. 7.1 North America Saxagliptin Sales by Country
  2. 7.1.1 North America Saxagliptin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Saxagliptin Sales by Country (2021-2026)
  4. 7.1.3 North America Saxagliptin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Saxagliptin Market Size by Country
  6. 7.2.1 North America Saxagliptin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Saxagliptin Market Size by Country (2021-2026)
  8. 7.2.3 North America Saxagliptin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Saxagliptin Sales by Country
  2. 8.1.1 Europe Saxagliptin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Saxagliptin Sales by Country (2021-2026)
  4. 8.1.3 Europe Saxagliptin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Saxagliptin Market Size by Country
  6. 8.2.1 Europe Saxagliptin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Saxagliptin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Saxagliptin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Saxagliptin Sales by Country
  2. 9.1.1 Asia-Pacific Saxagliptin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Saxagliptin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Saxagliptin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Saxagliptin Market Size by Country
  6. 9.2.1 Asia-Pacific Saxagliptin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Saxagliptin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Saxagliptin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Saxagliptin Sales by Country
  2. 10.1.1 South America Saxagliptin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Saxagliptin Sales by Country (2021-2026)
  4. 10.1.3 South America Saxagliptin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Saxagliptin Market Size by Country
  6. 10.2.1 South America Saxagliptin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Saxagliptin Market Size by Country (2021-2026)
  8. 10.2.3 South America Saxagliptin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Saxagliptin Sales by Country
  2. 11.1.1 Middle East and Africa Saxagliptin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Saxagliptin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Saxagliptin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Saxagliptin Market Size by Country
  6. 11.2.1 Middle East and Africa Saxagliptin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Saxagliptin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Saxagliptin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Saxagliptin Value Chain Analysis
  2. 12.1.1 Saxagliptin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Saxagliptin Production Mode & Process
  7. 12.2 Saxagliptin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Saxagliptin Distributors
  10. 12.2.3 Saxagliptin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst